Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 16.78
(0.96%)
HKD 16.78
(0.96%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.5 Billion CNY | 7.83% |
| 2022 | 10.67 Billion CNY | 2.24% |
| 2021 | 10.43 Billion CNY | 6.89% |
| 2020 | 9.76 Billion CNY | 2.89% |
| 2019 | 9.49 Billion CNY | 2.8% |
| 2018 | 9.23 Billion CNY | 149.49% |
| 2017 | 3.7 Billion CNY | 33.03% |
| 2016 | 2.78 Billion CNY | 9.34% |
| 2015 | 2.54 Billion CNY | -1.35% |
| 2014 | 2.57 Billion CNY | 14.82% |
| 2013 | 2.24 Billion CNY | 75.95% |
| 2012 | 1.27 Billion CNY | 48.59% |
| 2011 | 859 Million CNY | 13.77% |
| 2010 | 755.05 Million CNY | 34.71% |
| 2009 | 560.52 Million CNY | -11.46% |
| 2008 | 633.05 Million CNY | -55.38% |
| 2007 | 1.41 Billion CNY | 6.96% |
| 2006 | 1.32 Billion CNY | 15.49% |
| 2005 | 1.14 Billion CNY | 6.55% |
| 2004 | 1.07 Billion CNY | 0.98% |
| 2003 | 1.06 Billion CNY | 25.8% |
| 2002 | 848.51 Million CNY | 1.82% |
| 2001 | 833.32 Million CNY | 5.42% |
| 2000 | 790.46 Million CNY | 15.5% |
| 1999 | 684.38 Million CNY | -2.75% |
| 1998 | 703.72 Million CNY | -1.01% |
| 1997 | 710.92 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 10.75 Billion CNY | 9.16% |
| 2024 Q3 | 11.34 Billion CNY | 5.51% |
| 2024 Q1 | 9.84 Billion CNY | -14.41% |
| 2023 Q4 | 11.5 Billion CNY | 19.15% |
| 2023 Q3 | 9.65 Billion CNY | 5.4% |
| 2023 Q1 | 8.94 Billion CNY | -16.18% |
| 2023 FY | 11.5 Billion CNY | 7.83% |
| 2023 Q2 | 9.16 Billion CNY | 2.43% |
| 2022 Q3 | 8.43 Billion CNY | 3.03% |
| 2022 FY | 10.67 Billion CNY | 2.24% |
| 2022 Q4 | 10.67 Billion CNY | 26.44% |
| 2022 Q2 | 8.19 Billion CNY | -6.18% |
| 2022 Q1 | 8.73 Billion CNY | -16.35% |
| 2021 Q4 | 10.43 Billion CNY | 21.71% |
| 2021 Q2 | 8.16 Billion CNY | -2.04% |
| 2021 FY | 10.43 Billion CNY | 6.89% |
| 2021 Q3 | 8.57 Billion CNY | 5.08% |
| 2021 Q1 | 8.33 Billion CNY | -14.68% |
| 2020 Q1 | 8.74 Billion CNY | -7.9% |
| 2020 Q3 | 9.17 Billion CNY | 5.96% |
| 2020 Q2 | 8.65 Billion CNY | -0.97% |
| 2020 FY | 9.76 Billion CNY | 2.89% |
| 2020 Q4 | 9.76 Billion CNY | 6.46% |
| 2019 Q2 | 8.41 Billion CNY | 4.14% |
| 2019 Q1 | 8.07 Billion CNY | -12.48% |
| 2019 FY | 9.49 Billion CNY | 2.8% |
| 2019 Q3 | 9.04 Billion CNY | 7.45% |
| 2019 Q4 | 9.49 Billion CNY | 4.96% |
| 2018 FY | 9.23 Billion CNY | 149.49% |
| 2018 Q4 | 9.23 Billion CNY | 21.81% |
| 2018 Q3 | 7.57 Billion CNY | 8.14% |
| 2018 Q2 | 7 Billion CNY | 142.96% |
| 2018 Q1 | 2.88 Billion CNY | -22.04% |
| 2017 Q3 | 2.68 Billion CNY | 10.44% |
| 2017 Q4 | 3.7 Billion CNY | 37.75% |
| 2017 FY | 3.7 Billion CNY | 33.03% |
| 2017 Q2 | 2.43 Billion CNY | -14.26% |
| 2017 Q1 | 2.83 Billion CNY | 1.98% |
| 2016 Q3 | 2.45 Billion CNY | 9.32% |
| 2016 Q1 | 2.44 Billion CNY | -3.74% |
| 2016 FY | 2.78 Billion CNY | 9.34% |
| 2016 Q4 | 2.78 Billion CNY | 13.38% |
| 2016 Q2 | 2.24 Billion CNY | -8.36% |
| 2015 Q2 | 2.4 Billion CNY | 2.58% |
| 2015 FY | 2.54 Billion CNY | -1.35% |
| 2015 Q4 | 2.54 Billion CNY | 3.97% |
| 2015 Q3 | 2.44 Billion CNY | 1.64% |
| 2015 Q1 | 2.34 Billion CNY | -8.99% |
| 2014 Q1 | 2.26 Billion CNY | 1.04% |
| 2014 Q4 | 2.57 Billion CNY | -4.97% |
| 2014 FY | 2.57 Billion CNY | 14.82% |
| 2014 Q3 | 2.71 Billion CNY | 15.38% |
| 2014 Q2 | 2.35 Billion CNY | 3.63% |
| 2013 Q3 | 2.4 Billion CNY | 10.0% |
| 2013 Q4 | 2.24 Billion CNY | -6.69% |
| 2013 FY | 2.24 Billion CNY | 75.95% |
| 2013 Q1 | 1.43 Billion CNY | 12.79% |
| 2013 Q2 | 2.18 Billion CNY | 51.99% |
| 2012 Q3 | 1.1 Billion CNY | 25.69% |
| 2012 Q4 | 1.27 Billion CNY | 15.7% |
| 2012 Q1 | 795.32 Million CNY | -7.41% |
| 2012 FY | 1.27 Billion CNY | 48.59% |
| 2012 Q2 | 877.71 Million CNY | 10.36% |
| 2011 Q3 | 856.24 Million CNY | 7.42% |
| 2011 FY | 859 Million CNY | 13.77% |
| 2011 Q4 | 859 Million CNY | 0.32% |
| 2011 Q2 | 797.11 Million CNY | 1.6% |
| 2011 Q1 | 784.58 Million CNY | 3.91% |
| 2010 Q2 | 683.62 Million CNY | 9.4% |
| 2010 Q3 | 710.65 Million CNY | 3.95% |
| 2010 Q4 | 755.05 Million CNY | 6.25% |
| 2010 Q1 | 624.9 Million CNY | 11.49% |
| 2010 FY | 755.05 Million CNY | 34.71% |
| 2009 FY | 560.52 Million CNY | -11.46% |
| 2009 Q1 | 591.28 Million CNY | -6.6% |
| 2009 Q2 | 567.58 Million CNY | -4.01% |
| 2009 Q3 | 586.81 Million CNY | 3.39% |
| 2009 Q4 | 560.52 Million CNY | -4.48% |
| 2008 Q3 | 721.17 Million CNY | -34.97% |
| 2008 Q2 | 1.1 Billion CNY | 6.75% |
| 2008 Q1 | 1.03 Billion CNY | -26.78% |
| 2008 Q4 | 633.05 Million CNY | -12.22% |
| 2008 FY | 633.05 Million CNY | -55.38% |
| 2007 Q1 | 1.23 Billion CNY | -6.58% |
| 2007 FY | 1.41 Billion CNY | 6.96% |
| 2007 Q4 | 1.41 Billion CNY | 9.08% |
| 2007 Q3 | 1.3 Billion CNY | 10.85% |
| 2007 Q2 | 1.17 Billion CNY | -5.31% |
| 2006 Q3 | 1.21 Billion CNY | 11.21% |
| 2006 Q2 | 1.08 Billion CNY | -2.22% |
| 2006 FY | 1.32 Billion CNY | 15.49% |
| 2006 Q1 | 1.11 Billion CNY | -3.06% |
| 2006 Q4 | 1.32 Billion CNY | 9.56% |
| 2005 Q4 | 1.14 Billion CNY | 2.97% |
| 2005 Q3 | 1.11 Billion CNY | 6.34% |
| 2005 Q2 | 1.04 Billion CNY | 13.6% |
| 2005 Q1 | 923.36 Million CNY | -14.34% |
| 2005 FY | 1.14 Billion CNY | 6.55% |
| 2004 Q3 | 823.97 Million CNY | -2.65% |
| 2004 Q4 | 1.07 Billion CNY | 30.82% |
| 2004 Q2 | 846.37 Million CNY | -0.8% |
| 2004 FY | 1.07 Billion CNY | 0.98% |
| 2004 Q1 | 853.17 Million CNY | -20.07% |
| 2003 Q2 | 862.2 Million CNY | 8.85% |
| 2003 Q3 | 869.98 Million CNY | 0.9% |
| 2003 Q4 | 1.06 Billion CNY | 22.7% |
| 2003 FY | 1.06 Billion CNY | 25.8% |
| 2003 Q1 | 792.08 Million CNY | -6.65% |
| 2002 Q4 | 848.51 Million CNY | 22.92% |
| 2002 Q1 | 615.51 Million CNY | -26.14% |
| 2002 Q2 | 665.44 Million CNY | 8.11% |
| 2002 Q3 | 690.32 Million CNY | 3.74% |
| 2002 FY | 848.51 Million CNY | 1.82% |
| 2001 Q2 | 713.43 Million CNY | 0.0% |
| 2001 FY | 833.32 Million CNY | 5.42% |
| 2001 Q4 | 833.32 Million CNY | 0.0% |
| 2000 FY | 790.46 Million CNY | 15.5% |
| 2000 Q4 | 790.46 Million CNY | 0.0% |
| 1999 FY | 684.38 Million CNY | -2.75% |
| 1998 FY | 703.72 Million CNY | -1.01% |
| 1997 FY | 710.92 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -94243.697% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | -728.654% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -158290.912% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -3634.883% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -2565.001% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -3760.07% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -18217.014% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -11610.154% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -6453.13% |
| SSY Group Limited | 1.08 Billion HKD | -959.311% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -12464.393% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -3520.213% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 67.212% |